Bal Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bal Pharma Limited has informed the stock exchanges that its trading window for dealing in company securities will be closed starting 18 July 2025. The closure applies to designated persons and their immediate relatives, in line with the company's insider trading code and SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will reopen 48 hours after the company declares its unaudited financial results for the quarter ended 30 June 2025 (Q1 FY26). The exact date of the board meeting to approve these quarterly results will be communicated to the exchange separately. This is a routine compliance filing.
This is a standard insider trading compliance measure and does not signal any material event on its own. However, it indicates that Bal Pharma's Q1 FY26 results are likely to be announced in late July 2025, which investors should watch for as the next key catalyst for the stock.